New advances in pharmacogenomics (Q34014377)

30 July 2017

1 reference

title

New advances in pharmacogenomics (English)

1 reference

30 July 2017

1 reference

Destenaves B

1

1 reference

30 July 2017

Thomas F

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Current Opinion in Chemical Biology

30 July 2017

published in

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

440-444

1 reference

Evidence of interferon beta-1a dose response in relapsing-remitting MS: the OWIMS Study. The Once Weekly Interferon for MS Study Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Familial occurrence of hypersensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Prospects for whole-genome linkage disequilibrium mapping of common disease genes

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Can pharmacogenomics make a difference in drug development?

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Population choice in mapping genes for complex diseases

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

… as consortium plans free SNP map of human genome

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

A 4-Mb high-density single nucleotide polymorphism-based map around human APOE

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Proteomics in drug discovery

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Reading bits of genetic information: methods for single-nucleotide polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Direct genetic analysis by matrix-assisted laser desorption/ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

High density synthetic oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Association of cg2 and pfmdr1 genotype with chloroquine resistance in field samples of Plasmodium falciparum from Nigeria

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016/S1367-5931(00)00101-0

7 January 2021

10.1016/S1367-5931(00)00101-0

Identifiers

DOI

1 reference

30 July 2017

1 reference